Shots:

• Eli Lilly to acquire Protomer Technologies for ~$1B- with the achievement of future development and commercial milestones
• Earlier- Lilly led an equity investment in Protomer along with JDRF T1D fund that provides Lilly with 14% ownership of promotor and is currently acquiring the remaining shares of Protomer beyond the initial investment
• The acquisition will boost Lilly’s diabetes pipeline with the addition of Protomer's glucose-sensing insulin that can sense sugar levels in the blood and automatically activate as needed throughout the day

  Ref: Lilly | Image: Eli Lilly